The DOI matches its Crossref record.
Delirium in advanced cancer patients
Abstract
Delirium in advanced cancer is often poorly identified and inappropriately managed. It is one of the most common causes for admission to clinical institutions and is the most frequently cited psychiatric disorder in terminal cancer. Diagnosis of delirium is defined as a disturbance of consciousness and attention with a change in cognition and/or perception. In addition, it develops suddenly and follows a fluctuating course and it is related to other causes, such as cancer, metabolic disorders or the effects of drugs. Delirium occurs in 26% to 44% of cancer patients admitted to hospital or hospice. Of all advanced cancer patients, over 80% eventually experience delirium in their final days. In advanced cancer, delirium is a multifactorial syndrome where opioids factor in almost 60% of episodes. Delirium in such patients, excluding terminal delirium, may be reversible in 50% of cases. Providing adequate end-of-life care for a patient with delirium is the main challenge. The family needs advice and it is important to create a relaxing environment for the patient. The primary therapeutic approach is to identify the reversible causes of delirium. Some therapeutic strategies have been shown to be effective: reduction or withdrawal of the psychoactive medication, opioid rotation, and hydration. Haloperidol is the most frequently used drug, and new neuroleptics such as risperidone or olanzapine are being tested with good results. Methylphenidate has been used for hypoactive delirium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interventions for preventing delirium in hospitalised non-ICU patients
Siddiqi, N., Harrison, J. K., Clegg, A., Teale, E. A., Young, J., Taylor, J., & Simpkins, S. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005563.pub3 · Cited by 619
Lonergan, E., Britton, A. M., & Luxenberg, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005594.pub2 · Cited by 361
Maldonado, J. R. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2008.06.004 · Cited by 338
Delirium in the Acute Care Setting: Characteristics, Diagnosis and Treatment
Maldonado, J. R. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2008.05.008 · Cited by 283
Interventions for preventing delirium in hospitalised patients
Siddiqi, N., Holt, R., Britton, A. M., & Holmes, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005563.pub2 · Cited by 280
Bruera, E., Bush, S. H., Willey, J., Paraskevopoulos, T., Li, Z., Palmer, J. L., Cohen, M. Z., Sivesind, D., & Elsayem, A. (2009) · Cancer · doi:10.1002/cncr.24215 · Cited by 274
Self-citationPhenomenology of delirium: Assessment of 100 adult cases using standardised measures
Meagher, D. J., Moran, M., Raju, B., Gibbons, D., Donnelly, S., Saunders, J., & Trzepacz, P. T. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023911 · Cited by 259
de la Cruz, M., Fan, J., Yennu, S., Tanco, K., Shin, S., Wu, J., Liu, D., & Bruera, E. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2610-3 · Cited by 152
Self-citationDelgado‐Guay, M. O., Parsons, H. A., Li, Z., Palmer, L. J., & Bruera, E. (2009) · Cancer · doi:10.1002/cncr.24017 · Cited by 129
Self-citationPsychiatric Issues in Cancer Patients
Roth, A. J., & Jaeger, A. (2018) · The American Cancer Society's Principles of Oncology · doi:10.1002/9781119468868.ch29 · Cited by 2
Metadata
- Authors
- Centeno, C., Sanz, Á., & Bruera, E.
- Venue
- Palliative Medicine
- Publisher
- SAGE Publications
- Published
- 2004-04
- Volume
- 18
- Issue
- 3
- Pages
- 184-194
- ISSN
- 0269-2163 (ISSN-L)
- 1477-030X
- OpenAlex
- W2151746905
- Cited by
- 220
- References
- 0
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.